Abstract B44: Targeting Notch signaling with a dual Notch 2/3 antagonist, OMP-59R5, inhibits tumor growth and decreases cancer stem cell frequency in pancreatic cancer.
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2015 ◽
Keyword(s):
2010 ◽
Keyword(s):